About the Survey
The results of the Medical Group Management Association (MGMA)’s Annual Regulatory Burden survey reveal that medical practices continue to face overwhelming regulatory challenges. In many cases, the burden has increased year over year. This year’s annual report highlights the impact of the ongoing public health emergency and the government response. The regulatory burden associated with the COVID-19 pandemic quickly emerged as a top issue group practices are facing in 2021.
From measuring quality to completing prior authorization requirements, medical practices face mounting regulatory hurdles that interfere with clinical goals and improving patient outcomes. The Annual Regulatory Burden Survey provides MGMA with critical data on the real impact of federal policies and regulations, allowing us to better educate Congress and the Administration about obstacles to delivering high quality patient care.
This year’s survey responses demonstrate that there is still much to be done at the federal level to provide regulatory relief for medical groups. MGMA will continue to play a key role in the policy discussion to ensure that medical practices have a voice in Washington.
About the Respondents
The survey includes responses from executives representing over 400 group practices. 70% of respondents are in practices with less than 20 physicians and 10% are in practices with over 100 physicians. Over 80% of respondents are in independent practices.
With a membership of more than 60,000 medical practice administrators, executives, and leaders, MGMA represents more than 15,000 medical groups comprising more than 350,000 physicians. These groups range from small independent practices in remote and other underserved areas to large regional and national health systems that cover the full spectrum of physician specialties.